Clinical trial
A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test by Trained Personnel at Near-Patient and Point-of-Care Settings
NCT07569913 is registered in ClinicalTrials.gov with bioLytical Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test by Trained Personnel at Near-Patient and Point-of-Care Settings
- Lead sponsor
- bioLytical Laboratories
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- June 1, 2027
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b infection, hiv 2 infection, hiv1 infection, syphilis infection